Market Cap

Pharma Mar, SA Market Capitalization:

€1.31 Billion

EUR as of Jan. 1, 2026

US$1.54 Billion

business Pharma Mar, SA Company Profile

Pharma Mar, SA Main Stock Listing

BME: PHM

Market Capitalization History of Pharma Mar, SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Pharma Mar, SA market cap

Date Market Cap YoY Change
Jan. 1, 2026 €1.31 B -4.41%
Jan. 1, 2025 €1.37 B 85.95%
Jan. 1, 2024 €738.2 M -35.44%
Jan. 1, 2023 €1.14 B 13.10%
Jan. 1, 2022 €1.01 B -46.91%
Jan. 1, 2021 €1.90 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

Pharma Mar, SA Categories

Spain languages Healthcare languages Biotechnology
Spain Healthcare Spain Biotechnology

Stocks & Indices

Pharma Mar, SA has the following listings and related stock indices.


Stock: BME: PHM

Stock: FSX: PMRA

Stock: OTC: PHMMF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.